Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
about
Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumorsMechanism of transcriptional activation by the proto-oncogene Twist1Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells.Inhibition of p600 expression suppresses both invasiveness and anoikis resistance of gastric cancer.Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinomaTwist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis.Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.Anti-proliferation effects of Twist gene silencing in gastric cancer SGC7901 cells.Advances in biomarker research for pancreatic cancer.TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemiaInduction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic functionIdentification of a small optimal subset of CpG sites as bio-markers from high-throughput DNA methylation profilesPrognostic value of colorectal cancer biomarkers.Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract.LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.TWIST1 hypermethylation is observed in pancreatic cancer.Molecular pathology of pancreatic cancer: from bench-to-bedside translation.EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.Biomarkers for predicting future metastasis of human gastrointestinal tumors.Epithelial-mesenchymal transition in pancreatic carcinomaShould we consider cancers as embryonic diseases or as consequences of stem-cell deregulation?MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b.Twist expression associated with the epithelial-mesenchymal transition in gastric cancer.Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma.Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma.Identification of Sox6 as a regulator of pancreatic cancer development.Expression of TWIST in the first-trimester trophoblast and decidual tissue of women with recurrent pregnancy losses.TWIST1 upregulates the MAGEA4 oncogene.Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm.TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer.Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms.
P2860
Q27332624-40037211-D7B9-460E-83E8-170FC91A5148Q28512117-5444365A-96E8-4B8F-B523-FCFDFFA475B5Q33658808-225A706D-477D-46CD-B39D-F39DB8AB28B0Q33828971-83AAB544-84B9-4205-97B9-2E5FEF22896DQ33902453-5261B113-DA25-4A41-8F96-1207A862C222Q34288798-9ED35AF5-C7ED-43B9-9BFD-02D77A1AA173Q34438815-D9CFE4A0-E2AD-455D-8918-48EFAA517C99Q35169328-D6BFDD3A-9812-42F6-B687-F68F4A38EE95Q36126609-8A8375C9-FC5C-4055-8E0C-816003B12D98Q36356216-6A673BD6-54F7-4497-ADD1-16BEA9F5943BQ36545572-0F8D33C9-0583-480D-B39C-1DD4DF7EBDB8Q36662693-8A9AC095-7030-460E-9790-B721B13FAD7BQ37037183-ADF8CEE0-FB95-47C3-A651-AAFAAD90F978Q37132721-E046EB0A-190C-48B4-BC11-289FA3680A7EQ37210185-E1771521-CB3A-4CBC-9A07-109568D540ADQ37229941-201AD9A2-C98C-4EAB-B3BC-9F72D632081BQ37642045-E44AC315-C6AA-4FBB-8112-1A4001F836D2Q37998096-CFA654B9-5C51-4C86-8073-0D2BAA93A90AQ38040369-E0088746-F26E-4C77-9DDD-10413D6845FDQ38078237-859046C7-E78E-4B06-8605-8CB6856EFB37Q38166588-B095F5D2-9F19-4463-8F73-CBB1E60B138AQ38260890-A94DF244-862F-4C94-9E73-FD11A931C8BBQ38937658-BC3062CA-E56B-4730-8E4D-ECA5E0A2C982Q39348991-DBF3D7DB-FFFA-4DAF-80BA-73A33B164686Q39389689-A73DE692-01A0-4934-BD38-F1527BE38B4BQ40011207-A9618BA2-7C4A-49C4-A246-7F91E54249C0Q48166983-9EE0A3DC-BE84-4C1F-9C57-D25BD8A318BBQ48366211-F466AB70-88F7-4872-9A75-61FBC217B49BQ51456107-C4131C71-5440-4223-AE0C-04CA06F19DF8Q53275154-D897DFB2-A309-44B2-9B53-0AC71BD7F60BQ53316057-8A5C25EC-48B1-49AA-8F0B-EF801499DECAQ53618235-D2668C14-9391-441E-9A09-707E524411DEQ54361162-370FD17C-9A7A-45B1-8D84-8534714133AAQ54499438-9BC0C48F-DB57-4112-82A1-3F6BEAC30577
P2860
Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Twist, a novel oncogene, is up ...... xpression in pancreatic juice.
@en
Twist, a novel oncogene, is up ...... xpression in pancreatic juice.
@nl
type
label
Twist, a novel oncogene, is up ...... xpression in pancreatic juice.
@en
Twist, a novel oncogene, is up ...... xpression in pancreatic juice.
@nl
prefLabel
Twist, a novel oncogene, is up ...... xpression in pancreatic juice.
@en
Twist, a novel oncogene, is up ...... xpression in pancreatic juice.
@nl
P2093
P2860
P356
P1476
Twist, a novel oncogene, is up ...... xpression in pancreatic juice.
@en
P2093
Eishi Nagai
Hiroshi Yamaguchi
Hiroyuki Konomi
Kazuhiro Mizumoto
Koji Yamaguchi
Masao Tanaka
Masazumi Tsuneyoshi
Seiji Ohhashi
P2860
P304
P356
10.1002/IJC.22295
P577
2007-04-01T00:00:00Z